Sopharma AD Cash Flow Conversion Efficiency

Latest as of June 2025: -0.019x

Sopharma AD cash flow conversion efficiency. Based on the latest financial reports, Sopharma AD (SPH) has a cash flow conversion efficiency ratio of -0.019x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (zł-17.24 Million ≈ $-4.74 Million USD) by net assets (zł926.37 Million ≈ $254.95 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market cap of Sopharma AD for the company's overall valuation and market capitalisation.

Cash Flow Conversion Efficiency of Sopharma AD (2011–2024)

Cash flow conversion efficiency of Sopharma AD from 2011 to 2024. This chart illustrates how Sopharma AD's cash flow conversion efficiency has evolved over time, based on yearly financial data. View SPH stock price and chart for real-time trading data and today's change.

Sopharma AD Cash Flow Conversion Ratio Explained

Sopharma AD cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Sopharma AD Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Sopharma AD ranked by their cash flow conversion efficiency. Review cash generation quality of Sopharma AD to assess how much free cash flow the company generates relative to operating cash flow.

Company	Cash Flow Conversion Efficiency
GQG PARTNERS CDI/1/1 F:6P1	N/A
Compania Cervecerias Unidas SA ADR NYSE:CCU	-0.006x
Zhejiang Kaishan Compressor SHE:300257	0.028x
BM EUROP.UNSP.ADR /4 F:BMNU	N/A
Shriram Pistons & Rings Limited NSE:SHRIPISTON	0.091x
Aadhar Housing Finance Ltd NSE:AADHARHFC	-0.129x
Encore Capital Group Inc NASDAQ:ECPG	-0.027x
National Energy Services Reunited Corp Ordinary Shares NASDAQ:NESR	0.167x

Annual Cash Flow Conversion Efficiency for Sopharma AD (2011–2024)

The table below shows the annual cash flow conversion efficiency of Sopharma AD from 2011 to 2024. Also see SPH current and non-current assets for a full breakdown of the balance sheet.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	zł843.10 Million ≈ $232.03 Million	zł76.73 Million ≈ $21.12 Million	0.091x	+52.30%
2023-12-31	zł753.63 Million ≈ $207.41 Million	zł45.03 Million ≈ $12.39 Million	0.060x	-65.57%
2022-12-31	zł718.13 Million ≈ $197.64 Million	zł124.62 Million ≈ $34.30 Million	0.174x	+250.52%
2021-12-31	zł658.87 Million ≈ $181.33 Million	zł-75.96 Million ≈ $-20.91 Million	-0.115x	+63.59%
2020-12-31	zł566.60 Million ≈ $155.94 Million	zł-179.41 Million ≈ $-49.38 Million	-0.317x	-41.94%
2019-12-31	zł575.77 Million ≈ $158.46 Million	zł-128.44 Million ≈ $-35.35 Million	-0.223x	-500.25%
2018-12-31	zł508.53 Million ≈ $139.95 Million	zł28.34 Million ≈ $7.80 Million	0.056x	-29.89%
2017-12-31	zł503.11 Million ≈ $138.46 Million	zł40.00 Million ≈ $11.01 Million	0.080x	-22.88%
2016-12-31	zł491.22 Million ≈ $135.19 Million	zł50.64 Million ≈ $13.94 Million	0.103x	+121.34%
2015-12-31	zł457.64 Million ≈ $125.95 Million	zł21.31 Million ≈ $5.87 Million	0.047x	-0.37%
2014-12-31	zł431.64 Million ≈ $118.79 Million	zł20.18 Million ≈ $5.55 Million	0.047x	-34.03%
2013-12-31	zł412.77 Million ≈ $113.60 Million	zł29.25 Million ≈ $8.05 Million	0.071x	-21.21%
2012-12-31	zł391.35 Million ≈ $107.71 Million	zł35.20 Million ≈ $9.69 Million	0.090x	-14.33%
2011-12-31	zł365.81 Million ≈ $100.68 Million	zł38.40 Million ≈ $10.57 Million	0.105x	--

About Sopharma AD

WAR:SPH Poland Medical Distribution

Market Cap

$2.07 Billion

zł7.50 Billion PLN

Market Cap Rank

#5901 Global

#34 in Poland

Share Price

zł14.45

Change (1 day)

+12.45%

52-Week Range

zł7.12 - zł14.45

All Time High

zł17.83